Krishna Rao - Anthropic's CFO on Compute, Scaling to $30B ARR, and the Returns to Frontier Intelligence - [Invest Like the Best, EP.472]

Krishna Rao, CFO of Anthropic, discusses the critical role of compute procurement in scaling the company's AI operations. He explains the strategic challenges of balancing supply and demand to maintain a competitive edge at the frontier of intelligence.

Krishna Rao discusses Anthropic's strategic approach to compute procurement and allocation, emphasizing the importance of hardware flexibility across multiple chip platforms. He explains how the company manages the 'cone of uncertainty' in exponential growth while prioritizing long-term investments in frontier model development.

Krishna Rao discusses how Anthropic achieves efficiency gains alongside model intelligence improvements, enabling significant revenue growth. He explains that the high returns to frontier intelligence are driven by the enterprise sector's ability to unlock new use cases with each generation of more capable models.

Krishna Rao discusses how Anthropic leverages its own models, specifically Claude Code, to accelerate the development of future AI generations. He emphasizes that scaling laws remain robust and that the company maintains a research-first culture to guide these advancements.

Krishna Rao discusses Anthropic's dynamic approach to managing compute resources, including partnerships with SpaceX, Google, and Amazon to secure future capacity. The conversation highlights the complexities of balancing price-performance, speed, and chip-specific capabilities to meet rapidly evolving customer demand.

Krishna Rao discusses Anthropic's strategy of building a horizontal platform for developers while selectively creating vertical applications. He addresses concerns regarding competition with customers by emphasizing a partner-oriented approach and the rapid pace of model development.

Krishna Rao discusses Anthropic's approach to pricing models like Claude, emphasizing the importance of stability and the Jevons paradox in driving customer value. He also explains how the company manages compute resources and maintains deep, multifaceted partnerships with major cloud providers and chip manufacturers.

Krishna Rao discusses how Anthropic's finance team utilizes Claude to automate complex tasks like financial reporting and tax analysis, significantly increasing productivity. He also reflects on the evolving nature of investor interactions as the company scales and matures.

Krishna Rao discusses the rapid scaling of Anthropic and the strategic importance of balancing frontier model development with AI safety and interpretability. He explains how the company's commitment to responsible AI has become a competitive advantage in securing enterprise partnerships.

Krishna Rao discusses the unique fungibility of compute resources at Anthropic and the importance of demonstrating clear ROI to customers and investors. He also addresses the industry's challenge in improving public perception of AI by highlighting its potential for societal benefits like healthcare and drug development.

Krishna Rao discusses the strategic release of the Mythos model, emphasizing a phased approach to mitigate security risks while maintaining innovation. He also highlights the importance of collaborating with the U.S. government to establish responsible AI deployment frameworks.

Krishna Rao discusses the unique, collaborative, and transparent culture at Anthropic, emphasizing its role in talent retention and mission alignment. He highlights how the company prioritizes intellectual honesty and responsible development of transformative AI technology over individual credit or internal politics.

Krishna Rao discusses Anthropic's focus on building virtual collaborators to enhance enterprise productivity and knowledge work. He also reflects on the challenges of scaling as an executive and the importance of first-principles thinking in a rapidly evolving AI landscape.

Krishna Rao discusses the rapid evolution of AI capabilities and the potential for these advancements to revolutionize drug discovery and healthcare outcomes. He also shares a personal reflection on the sacrifices made by his brother to ensure his future educational opportunities.